In a groundbreaking advancement in the field of catalysis, researchers have unveiled a sodium-doped, transition metal-free amorphous silicon-boron-nitride (SiBN) ceramic…
After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) candidate from a clinical…